Ciclesonide for the treatment of seasonal allergic rhinitis

Expert Review of Clinical Immunology

Volumn 7, Issue 6, 2011, Pages 735-741

  Jacobs, Robert L ^a  

^a Biogenics Research Chamber   (United States)

Author keywords

allergic rhinitis; ciclesonide; intranasal corticosteroids

Indexed keywords

BECLOMETASONE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE;

ARTICLE; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; ECONOMIC ASPECT; HAY FEVER; HUMAN; INCIDENCE; SOCIAL ASPECT; SYMPTOM;

ANTI-ALLERGIC AGENTS; HUMANS; INCIDENCE; PREGNENEDIONES; RHINITIS, ALLERGIC, SEASONAL;

EID: 80054898978     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.70     Document Type: Article

References (39)

1. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol. 108, S2-S8 (2001)
2. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 28, 3-9 (2007)
3. Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc. 31(5), 375-380 (2010)
4. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 62(Suppl. 85), 17-25 (2007)
5. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 62(Suppl. 85), 9-16 (2007)
6. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J. Pharmacol. Exp. Ther. 309(1), 249-258 (2004)
7. Rohatagi S, Luo L, Shen L, et al. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. Am. J. Ther. 12(3), 201-209 (2005)
8. Sato H, Nave R, Nonaka T, et al. Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa. BMC Pharmacol. 7, 7 (2007)
9. Belvisi MG, Bundschuh DS, Stoeck M,, et al. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma. J. Pharmacol. Exp. Ther. 314(2), 568-574 (2005)
10. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc. Am. Thorac. Soc. 1(4), 356-363 (2004)
11. Nave R, Bethke TD, van Marle SP, Zech K. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin. Pharmacokinet. 43(7), 479-486 (2004)
12. Mutch E, Nave R, McCracken N, Zech K, Williams FM. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem. Pharmacol. 73, 1657-1664 (2007)
13. Nave R, Drollmann A, Steinijans VW, Bethke TD. Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin. Int. J. Clin. Pharmacol. Ther. 43(6), 264-270 (2005)
14. Bohmer GM, Drollmann A, Gleiter CH, Nave R. Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl- ciclesonide. Clin. Pharmacokinet. 47(5), 343-349 (2008)
15. Kim K, Quesada J, Szmaydy-Rikken N, et al. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. J. Asthma 44, 515-520 (2007)
16. Ratner P, Darken P, Wingertzahn M, Shah T. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis. J. Asthma 44, 629-633 (2007)
17. Agertoft L, Pedersen S. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J. Allergy Clin. Immunol. 115, 940-945 (2005)
18. Szefler S, Rohatagi S, Williams J, et al. Ciclesonide, a novel inhaled steroid, does not affect HPA-axis function in patients with moderate-to-severe persistent asthma. Chest 128, 1104-1114 (2005)
19. Lipworth BJ, Kaliner MA, LaForce CF, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary- adrenal axis function in adults with mild-to-moderate persistent asthma. Ann. Allergy Asthma Immunol. 94, 465-472 (2005)
20. Nave R, Herzog R, Laurent A, Wingertzahn MA. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers. Clin. Ther. 31, 2988-2999 (2009)
21. Ratner P, Wingertzahn MA, Herzog R, et al. An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis. Pulm. Pharmacol. Ther. (2011) (In Press)
22. Ratner PH, Wingertzahn MA, van Bavel JH, et al. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 97, 657-663 (2006)
23. Ratner PH, Wingertzahn MA, van Bavel JH, Hampel F, Darken PF, Shah T. Efficacy and safety of ciclesnide nasal spray for the treatment of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 118, 1142-1148 (2006)
24. Patel P, Patel D, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear Nose Throat J. 87(6), 340-353 (2008)
25. Couroux P, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 102, 62-68 (2009)
26. LaForce C, van Bavel J, Meltzer EO, Wingertzahn MA. Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treament of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 103, 166-173 (2009)
27. Ratner PH, Jacobs RL, Mohar D, Huang H, Desai SY, Hinkle J. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 micrograms once daily, for the treatment of seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 105, 471-479 (2010)
28. Howland W, Ratner P, Martin B, et al. A study evaluating the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in the relief of nasal symptoms of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 127(2), AB200 (2011)
29. Martin B, Ratner P, Howland W, et al. An evaluation of the effect of ciclesonide hydrofluoroalkane nasal aerosol on the ocular symptoms of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 127(2), AB201 (2011)
30. Andrews C, Ratner P, Martin B, et al. Results of the Rhinoconjunctivitis Related Quality of Life Questionnaire administered to subjects with seasonal allergic rhinitis following treatment with ciclesonide hydrofluoroalkane nasal aerosol. J. Allergy Clin. Immunol. 127(2), AB257 (2011)
31. Bielory L, Blaiss M, Fineman SM, et al. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology. Ann. Allergy Asthma Immunol. 96, 514-525 (2006)
32. Nave R, Wingerzahn MA, Brookman S, Kaida S, Matsunaga T. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis. J. Clin. Pharmacol. 46(4), 461-467 (2006)
33. Meltzer EO, Derendorf H. The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide. Ann. Allergy Asthma Immunol. 97, 149-157 (2006)
34. Meltzer EO. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Ann. Allergy Asthma Immunol. 98, 12-21 (2007)
35. Strachan DP. Hay fever, hygiene, and household size. BMJ 299, 1259-1260 (1989)
36. Strachan DP. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax 55(Suppl. 1), S2-S10 (2000)
37. D'Amato G, Cecchi L. Effects of climate change on environmental factors in respiratory allergic disease. Clin. Exp. Allergy 38(8), 1264-1274 (2008)
38. Shea KM, Truckner RT, Peden DB. Climate change and allergic disease. J. Allergy Clin. Immunol. 122(3), 443-453 (2008)
39. Ziska L, Knowlton K, Rogers C, et al. Recent warming by latitude associated with increased length of ragweed pollen season in central North America. Proc. Natl Acad. Sci. USA 108, 4248-4251 (2011)